Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial to Determine the Efficacy of Secukinumab in Active Non-segmental Vitiligo

NCT05676333 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT05676333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05676333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial to Determine the Efficacy of Secukinumab in Active Non-segmental Vitiligo
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Completed
Start date
October 12, 2016
Completion date
February 22, 2019
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secukinumab, vitiligo